Connect Biopharma Holdings Limited (CNTB) vs MiNK Therapeutics, Inc. (INKT)
A side-by-side comparison of Connect Biopharma Holdings Limited and MiNK Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.96HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
INKT
MiNK Therapeutics, Inc.
$11.71HealthcareDelayed quote: Oct 6, 2026, 11:29 AM EDT
Total return — CNTB vs INKT
growth of $100 · dividends reinvested · last 5yCNTB -94.8% (-44.6%/yr)INKT -89.8% (-36.7%/yr)INKT compounded faster over this window
CNTB INKT
CNTB vs INKT: by the numbers
- •CNTB is the larger company ($60M vs $58M market cap).
- •Both run net losses; INKT's is the smaller (0.00% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | INKT |
|---|---|---|
| P/B ratio | 2.25 | N/A |
Profitability
| Metric | CNTB | INKT |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -90740.62% | 0.00% |
| Net margin | -86687.50% | 0.00% |
| ROE | -132.16% | N/A |
| ROIC | -136.77% | -604.20% |
Growth (annualized)
| Metric | CNTB | INKT |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.